1Kazuhiro Yoshida,Kazuaki Tanabe,Hideaki Ueno,Kouji Ohta,Jun Hihara,Tetsuya Toge,Masahiko Nishiyama. Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study[J] 2003,Gastric Cancer(1):82～89
4Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy[J]. Cancer Sci, 2008,99 (2) : 187-194.
5Olaussen K A,Dunant A,Fouret P,et al. DNA repair by ERCC1 in non small-cell lung cancer and cisplatin-based adjuvant chemotherapy[J]. N EnglJ Med,2006,355(10):983-991.
6Grondin S C, Liptay M J. Current concepts in the staging of nonsmall cell lung cancer[J]. Surg Oncol,2002,11 (4) : 181-190.
7Raderschall E, Stout K, Freier S, et al. Elevated levels of Rad51 recombination protein in tumor cells [J]. Cancer Res, 2002, 62( 1 ) : 219-225.
8Sonoda E, Sasaki M S, Buerstedde J M, et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death [J]. EMBOJ, 1998,17(2) :598-608.
9Collis S J, Tighe A, Scott S D, et al. Ribozyme minigene-mediated RADS1 down-regulation increases radiosensitivity of human prostate cancer cells[J]. Nucleic Acids Res,2001,29(7):1534-1538.
10Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy[J]. Cancer Sci, 2008,99 (2) : 187-194.
